nodes	percent_of_prediction	percent_of_DWPC	metapath
Halothane—ALB—Vismodegib—skin cancer	0.121	0.167	CbGbCtD
Halothane—ALB—Vemurafenib—skin cancer	0.0954	0.132	CbGbCtD
Halothane—CYP2E1—Dacarbazine—skin cancer	0.0756	0.104	CbGbCtD
Halothane—CYP2A6—Fluorouracil—skin cancer	0.0672	0.0928	CbGbCtD
Halothane—CYP2C9—Vismodegib—skin cancer	0.065	0.0898	CbGbCtD
Halothane—CYP3A4—Temozolomide—skin cancer	0.0545	0.0754	CbGbCtD
Halothane—CYP3A4—Imiquimod—skin cancer	0.0545	0.0754	CbGbCtD
Halothane—CYP2D6—Vemurafenib—skin cancer	0.047	0.0649	CbGbCtD
Halothane—ALB—Fluorouracil—skin cancer	0.0428	0.0592	CbGbCtD
Halothane—CYP3A4—Vismodegib—skin cancer	0.0378	0.0522	CbGbCtD
Halothane—CYP3A4—Vemurafenib—skin cancer	0.0299	0.0413	CbGbCtD
Halothane—CYP2C9—Fluorouracil—skin cancer	0.0231	0.0319	CbGbCtD
Halothane—RHO—nerve—skin cancer	0.0168	0.0881	CbGeAlD
Halothane—KCNJ6—nerve—skin cancer	0.0157	0.0824	CbGeAlD
Halothane—CYP3A4—Docetaxel—skin cancer	0.0103	0.0142	CbGbCtD
Halothane—GABRQ—nerve—skin cancer	0.00665	0.0348	CbGeAlD
Halothane—RHO—epithelium—skin cancer	0.00643	0.0337	CbGeAlD
Halothane—GRIN2A—nerve—skin cancer	0.00539	0.0282	CbGeAlD
Halothane—ATP2C1—skin epidermis—skin cancer	0.00483	0.0253	CbGeAlD
Halothane—KCNJ6—female reproductive system—skin cancer	0.00447	0.0234	CbGeAlD
Halothane—ATP2C1—nerve—skin cancer	0.00411	0.0215	CbGeAlD
Halothane—RHO—head—skin cancer	0.00399	0.0209	CbGeAlD
Halothane—GNG2—skin of body—skin cancer	0.00394	0.0206	CbGeAlD
Halothane—KCNJ6—head—skin cancer	0.00373	0.0195	CbGeAlD
Halothane—ATP2C1—hair follicle—skin cancer	0.00344	0.018	CbGeAlD
Halothane—KCNMA1—blood vessel—skin cancer	0.0033	0.0173	CbGeAlD
Halothane—GNG2—lymphoid tissue—skin cancer	0.00319	0.0167	CbGeAlD
Halothane—KCNN4—nipple—skin cancer	0.00312	0.0163	CbGeAlD
Halothane—KCNJ3—head—skin cancer	0.00308	0.0161	CbGeAlD
Halothane—GNG2—female reproductive system—skin cancer	0.00308	0.0161	CbGeAlD
Halothane—ND1—neck—skin cancer	0.0029	0.0152	CbGeAlD
Halothane—GABRE—hair follicle—skin cancer	0.00258	0.0135	CbGeAlD
Halothane—GNG2—head—skin cancer	0.00257	0.0135	CbGeAlD
Halothane—ATP5D—nipple—skin cancer	0.00237	0.0124	CbGeAlD
Halothane—GABRA3—neck—skin cancer	0.00234	0.0123	CbGeAlD
Halothane—ATP2C1—nipple—skin cancer	0.00234	0.0122	CbGeAlD
Halothane—GABRP—nipple—skin cancer	0.00229	0.012	CbGeAlD
Halothane—KCNK3—female reproductive system—skin cancer	0.00212	0.0111	CbGeAlD
Halothane—KCNN4—epithelium—skin cancer	0.0021	0.011	CbGeAlD
Halothane—KCNK10—head—skin cancer	0.00196	0.0103	CbGeAlD
Halothane—KCNK9—head—skin cancer	0.00195	0.0102	CbGeAlD
Halothane—ND1—skin of body—skin cancer	0.00188	0.00984	CbGeAlD
Halothane—GNG2—lymph node—skin cancer	0.0018	0.00943	CbGeAlD
Halothane—KCNK3—head—skin cancer	0.00177	0.00926	CbGeAlD
Halothane—GABRE—nipple—skin cancer	0.00175	0.00915	CbGeAlD
Halothane—ATP5D—connective tissue—skin cancer	0.00168	0.00878	CbGeAlD
Halothane—KCNN4—lymphoid tissue—skin cancer	0.00162	0.00848	CbGeAlD
Halothane—GRIN3A—head—skin cancer	0.00162	0.00847	CbGeAlD
Halothane—KCNMA1—epithelium—skin cancer	0.00161	0.00842	CbGeAlD
Halothane—GABRQ—head—skin cancer	0.00158	0.00826	CbGeAlD
Halothane—KCNN4—female reproductive system—skin cancer	0.00156	0.00817	CbGeAlD
Halothane—GLRB—head—skin cancer	0.00153	0.00803	CbGeAlD
Halothane—ND1—lymphoid tissue—skin cancer	0.00152	0.00797	CbGeAlD
Halothane—ATP2C1—skin of body—skin cancer	0.0015	0.00783	CbGeAlD
Halothane—ND1—female reproductive system—skin cancer	0.00147	0.00769	CbGeAlD
Halothane—ATP5D—mammalian vulva—skin cancer	0.00138	0.00723	CbGeAlD
Halothane—GABRG3—head—skin cancer	0.00138	0.00723	CbGeAlD
Halothane—ATP2C1—mammalian vulva—skin cancer	0.00136	0.00714	CbGeAlD
Halothane—GABRA4—mammalian vulva—skin cancer	0.00135	0.00705	CbGeAlD
Halothane—KCNN4—head—skin cancer	0.0013	0.00683	CbGeAlD
Halothane—KCNK2—lymph node—skin cancer	0.00128	0.00672	CbGeAlD
Halothane—GRIN2A—head—skin cancer	0.00128	0.0067	CbGeAlD
Halothane—ND1—head—skin cancer	0.00123	0.00642	CbGeAlD
Halothane—ATP2C1—lymphoid tissue—skin cancer	0.00121	0.00634	CbGeAlD
Halothane—KCNMA1—female reproductive system—skin cancer	0.00119	0.00625	CbGeAlD
Halothane—ATP5D—female reproductive system—skin cancer	0.00118	0.0062	CbGeAlD
Halothane—ATP2C1—female reproductive system—skin cancer	0.00117	0.00611	CbGeAlD
Halothane—GABRP—female reproductive system—skin cancer	0.00115	0.00599	CbGeAlD
Halothane—GABRD—head—skin cancer	0.00114	0.00599	CbGeAlD
Halothane—GABRG1—head—skin cancer	0.0011	0.00576	CbGeAlD
Halothane—GABRA6—head—skin cancer	0.00109	0.00573	CbGeAlD
Halothane—GLRB—lymph node—skin cancer	0.00107	0.00562	CbGeAlD
Halothane—GABRB1—head—skin cancer	0.00107	0.00559	CbGeAlD
Halothane—GABRA5—head—skin cancer	0.00106	0.00556	CbGeAlD
Halothane—GABRB3—connective tissue—skin cancer	0.00105	0.0055	CbGeAlD
Halothane—GABRE—mammalian vulva—skin cancer	0.00102	0.00534	CbGeAlD
Halothane—KCNMA1—head—skin cancer	0.000998	0.00522	CbGeAlD
Halothane—GABRA3—head—skin cancer	0.000989	0.00518	CbGeAlD
Halothane—ATP5D—head—skin cancer	0.000989	0.00518	CbGeAlD
Halothane—ATP2C1—head—skin cancer	0.000976	0.00511	CbGeAlD
Halothane—GABRA4—head—skin cancer	0.000964	0.00504	CbGeAlD
Halothane—GABRP—head—skin cancer	0.000957	0.00501	CbGeAlD
Halothane—KCNN4—lymph node—skin cancer	0.000914	0.00478	CbGeAlD
Halothane—GABRE—female reproductive system—skin cancer	0.000874	0.00458	CbGeAlD
Halothane—ND1—lymph node—skin cancer	0.000859	0.0045	CbGeAlD
Halothane—GABRB2—head—skin cancer	0.000806	0.00422	CbGeAlD
Halothane—GABRG2—head—skin cancer	0.000806	0.00422	CbGeAlD
Halothane—GABRB3—female reproductive system—skin cancer	0.000741	0.00388	CbGeAlD
Halothane—GABRA2—head—skin cancer	0.000736	0.00385	CbGeAlD
Halothane—GABRE—head—skin cancer	0.00073	0.00382	CbGeAlD
Halothane—GABRA1—head—skin cancer	0.000712	0.00373	CbGeAlD
Halothane—KCNMA1—lymph node—skin cancer	0.000699	0.00366	CbGeAlD
Halothane—ATP5D—lymph node—skin cancer	0.000692	0.00362	CbGeAlD
Halothane—ATP2C1—lymph node—skin cancer	0.000683	0.00358	CbGeAlD
Halothane—CYP2B6—skin of body—skin cancer	0.000643	0.00337	CbGeAlD
Halothane—GABRB3—head—skin cancer	0.000619	0.00324	CbGeAlD
Halothane—CYP2B6—lymphoid tissue—skin cancer	0.000521	0.00273	CbGeAlD
Halothane—GABRA2—lymph node—skin cancer	0.000516	0.0027	CbGeAlD
Halothane—GABRE—lymph node—skin cancer	0.000511	0.00268	CbGeAlD
Halothane—CYP2B6—female reproductive system—skin cancer	0.000502	0.00263	CbGeAlD
Halothane—CYP2C9—female reproductive system—skin cancer	0.000497	0.0026	CbGeAlD
Halothane—CYP2E1—lymphoid tissue—skin cancer	0.000489	0.00256	CbGeAlD
Halothane—CYP2E1—female reproductive system—skin cancer	0.000471	0.00247	CbGeAlD
Halothane—ALB—lymph node—skin cancer	0.000466	0.00244	CbGeAlD
Halothane—CYP2B6—head—skin cancer	0.00042	0.0022	CbGeAlD
Halothane—CYP2E1—head—skin cancer	0.000394	0.00206	CbGeAlD
Halothane—CYP3A4—female reproductive system—skin cancer	0.000379	0.00199	CbGeAlD
Halothane—CYP2D6—female reproductive system—skin cancer	0.000373	0.00195	CbGeAlD
Halothane—CYP2D6—head—skin cancer	0.000312	0.00163	CbGeAlD
Halothane—ND1—Metabolism—CSPG4—skin cancer	0.000156	0.00183	CbGpPWpGaD
Halothane—ATP5D—Metabolism—CSPG4—skin cancer	0.000156	0.00183	CbGpPWpGaD
Halothane—GABRB2—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000156	0.00183	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—SHH—skin cancer	0.000155	0.00181	CbGpPWpGaD
Halothane—GRIN2A—Alzheimers Disease—TP53—skin cancer	0.000154	0.00181	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—RASA1—skin cancer	0.000154	0.0018	CbGpPWpGaD
Halothane—GNG2—Metabolism—PLIN2—skin cancer	0.000153	0.00179	CbGpPWpGaD
Halothane—GRIN2A—Transmission across Chemical Synapses—BRAF—skin cancer	0.000153	0.00179	CbGpPWpGaD
Halothane—KCNJ6—Neuronal System—HRAS—skin cancer	0.000152	0.00179	CbGpPWpGaD
Halothane—GABRA5—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000152	0.00178	CbGpPWpGaD
Halothane—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	0.000149	0.00175	CbGpPWpGaD
Halothane—GABRA3—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000149	0.00175	CbGpPWpGaD
Halothane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	0.000147	0.00172	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—SMO—skin cancer	0.000146	0.00172	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—PTCH1—skin cancer	0.000146	0.00172	CbGpPWpGaD
Halothane—GABRA2—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000146	0.00172	CbGpPWpGaD
Halothane—GABRB3—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000145	0.00171	CbGpPWpGaD
Halothane—KCNMA1—Neuronal System—BRAF—skin cancer	0.000144	0.00169	CbGpPWpGaD
Halothane—GNG2—Neuronal System—BRAF—skin cancer	0.000143	0.00168	CbGpPWpGaD
Halothane—GABRG2—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000143	0.00167	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—PTGER4—skin cancer	0.000143	0.00167	CbGpPWpGaD
Halothane—ALB—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000141	0.00165	CbGpPWpGaD
Halothane—KCNJ3—Neuronal System—HRAS—skin cancer	0.000139	0.00164	CbGpPWpGaD
Halothane—RHO—Disease—FOXO4—skin cancer	0.000139	0.00164	CbGpPWpGaD
Halothane—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	0.000139	0.00163	CbGpPWpGaD
Halothane—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	0.000137	0.00161	CbGpPWpGaD
Halothane—GABRQ—Transmission across Chemical Synapses—BRAF—skin cancer	0.000136	0.0016	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—PTCH2—skin cancer	0.000136	0.0016	CbGpPWpGaD
Halothane—CYP2A6—Fluoropyrimidine Activity—TP53—skin cancer	0.000129	0.00152	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—FOXO4—skin cancer	0.000126	0.00148	CbGpPWpGaD
Halothane—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	0.000126	0.00147	CbGpPWpGaD
Halothane—GABRA1—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000125	0.00146	CbGpPWpGaD
Halothane—GNG2—Metabolism—CSPG4—skin cancer	0.000123	0.00145	CbGpPWpGaD
Halothane—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	0.000122	0.00143	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—PTGER4—skin cancer	0.000121	0.00141	CbGpPWpGaD
Halothane—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	0.00012	0.00141	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—SHH—skin cancer	0.00012	0.00141	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—RASA1—skin cancer	0.000119	0.0014	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—SHH—skin cancer	0.000119	0.00139	CbGpPWpGaD
Halothane—KCNN4—Neuronal System—HRAS—skin cancer	0.000119	0.00139	CbGpPWpGaD
Halothane—KCNK18—Neuronal System—HRAS—skin cancer	0.000119	0.00139	CbGpPWpGaD
Halothane—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	0.000118	0.00138	CbGpPWpGaD
Halothane—GRIN2A—Neuronal System—BRAF—skin cancer	0.000117	0.00137	CbGpPWpGaD
Halothane—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	0.000117	0.00137	CbGpPWpGaD
Halothane—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	0.000115	0.00135	CbGpPWpGaD
Halothane—GNG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	0.000115	0.00134	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—PTCH1—skin cancer	0.000114	0.00133	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—SMO—skin cancer	0.000114	0.00133	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—PTCH1—skin cancer	0.000112	0.00132	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—SMO—skin cancer	0.000112	0.00132	CbGpPWpGaD
Halothane—GABRG3—Transmission across Chemical Synapses—BRAF—skin cancer	0.000112	0.00132	CbGpPWpGaD
Halothane—GNG2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.000111	0.0013	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—PTGER4—skin cancer	0.000111	0.0013	CbGpPWpGaD
Halothane—GABRB1—Transmission across Chemical Synapses—BRAF—skin cancer	0.000111	0.0013	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—PTGER4—skin cancer	0.000109	0.00128	CbGpPWpGaD
Halothane—ATP5D—Metabolism—ENO2—skin cancer	0.000106	0.00125	CbGpPWpGaD
Halothane—ND1—Metabolism—ENO2—skin cancer	0.000106	0.00125	CbGpPWpGaD
Halothane—GABRA6—Transmission across Chemical Synapses—BRAF—skin cancer	0.000105	0.00123	CbGpPWpGaD
Halothane—GABRQ—Neuronal System—BRAF—skin cancer	0.000104	0.00122	CbGpPWpGaD
Halothane—GABRA4—Transmission across Chemical Synapses—BRAF—skin cancer	0.000103	0.00121	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—GLI2—skin cancer	0.000103	0.00121	CbGpPWpGaD
Halothane—GNG2—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	0.000101	0.00119	CbGpPWpGaD
Halothane—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	0.0001	0.00118	CbGpPWpGaD
Halothane—RHO—Disease—ERCC2—skin cancer	9.94e-05	0.00117	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—MC1R—skin cancer	9.83e-05	0.00115	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—FOXO4—skin cancer	9.77e-05	0.00115	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—GLI1—skin cancer	9.69e-05	0.00114	CbGpPWpGaD
Halothane—KCNK10—Neuronal System—HRAS—skin cancer	9.67e-05	0.00113	CbGpPWpGaD
Halothane—GNG2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	9.56e-05	0.00112	CbGpPWpGaD
Halothane—GABRB2—Transmission across Chemical Synapses—BRAF—skin cancer	9.44e-05	0.00111	CbGpPWpGaD
Halothane—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	9.35e-05	0.0011	CbGpPWpGaD
Halothane—RHO—Disease—TERT—skin cancer	9.32e-05	0.00109	CbGpPWpGaD
Halothane—KCNK2—Neuronal System—HRAS—skin cancer	9.24e-05	0.00108	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—SUFU—skin cancer	9.19e-05	0.00108	CbGpPWpGaD
Halothane—GABRA5—Transmission across Chemical Synapses—BRAF—skin cancer	9.17e-05	0.00108	CbGpPWpGaD
Halothane—KCNMA1—Circadian rythm related genes—TP53—skin cancer	9.02e-05	0.00106	CbGpPWpGaD
Halothane—GABRA3—Transmission across Chemical Synapses—BRAF—skin cancer	9.01e-05	0.00106	CbGpPWpGaD
Halothane—KCNK3—Neuronal System—HRAS—skin cancer	8.99e-05	0.00105	CbGpPWpGaD
Halothane—KCNK9—Neuronal System—HRAS—skin cancer	8.99e-05	0.00105	CbGpPWpGaD
Halothane—GABRA2—Transmission across Chemical Synapses—BRAF—skin cancer	8.85e-05	0.00104	CbGpPWpGaD
Halothane—GABRB3—Transmission across Chemical Synapses—BRAF—skin cancer	8.79e-05	0.00103	CbGpPWpGaD
Halothane—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	8.66e-05	0.00102	CbGpPWpGaD
Halothane—GABRG2—Transmission across Chemical Synapses—BRAF—skin cancer	8.64e-05	0.00101	CbGpPWpGaD
Halothane—GNG2—Transmission across Chemical Synapses—HRAS—skin cancer	8.61e-05	0.00101	CbGpPWpGaD
Halothane—GABRG3—Neuronal System—BRAF—skin cancer	8.6e-05	0.00101	CbGpPWpGaD
Halothane—GABRB1—Neuronal System—BRAF—skin cancer	8.47e-05	0.000993	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—TERT—skin cancer	8.41e-05	0.000987	CbGpPWpGaD
Halothane—GNG2—Metabolism—ENO2—skin cancer	8.38e-05	0.000983	CbGpPWpGaD
Halothane—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	8.33e-05	0.000978	CbGpPWpGaD
Halothane—KCNMA1—Circadian rythm related genes—IL6—skin cancer	8.26e-05	0.000969	CbGpPWpGaD
Halothane—GNG2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	8.13e-05	0.000953	CbGpPWpGaD
Halothane—GABRA6—Neuronal System—BRAF—skin cancer	8.01e-05	0.00094	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	7.92e-05	0.00093	CbGpPWpGaD
Halothane—GABRA4—Neuronal System—BRAF—skin cancer	7.91e-05	0.000928	CbGpPWpGaD
Halothane—GNG2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	7.78e-05	0.000913	CbGpPWpGaD
Halothane—GABRA1—Transmission across Chemical Synapses—BRAF—skin cancer	7.55e-05	0.000886	CbGpPWpGaD
Halothane—RHO—Disease—BRAF—skin cancer	7.38e-05	0.000866	CbGpPWpGaD
Halothane—GABRB2—Neuronal System—BRAF—skin cancer	7.24e-05	0.000849	CbGpPWpGaD
Halothane—ALB—Transmembrane transport of small molecules—SLC12A2—skin cancer	7.14e-05	0.000838	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—NRAS—skin cancer	7.09e-05	0.000832	CbGpPWpGaD
Halothane—GABRA5—Neuronal System—BRAF—skin cancer	7.03e-05	0.000825	CbGpPWpGaD
Halothane—GRIN2A—Transmission across Chemical Synapses—HRAS—skin cancer	7.03e-05	0.000825	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—SHH—skin cancer	7.01e-05	0.000822	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—RASA1—skin cancer	6.96e-05	0.000817	CbGpPWpGaD
Halothane—GABRA3—Neuronal System—BRAF—skin cancer	6.9e-05	0.00081	CbGpPWpGaD
Halothane—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	6.86e-05	0.000805	CbGpPWpGaD
Halothane—GABRA2—Neuronal System—BRAF—skin cancer	6.78e-05	0.000796	CbGpPWpGaD
Halothane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	6.76e-05	0.000793	CbGpPWpGaD
Halothane—GABRB3—Neuronal System—BRAF—skin cancer	6.74e-05	0.000791	CbGpPWpGaD
Halothane—ALB—Selenium Micronutrient Network—PTGS2—skin cancer	6.73e-05	0.00079	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—BRAF—skin cancer	6.66e-05	0.000782	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—SMO—skin cancer	6.64e-05	0.000779	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—PTCH1—skin cancer	6.64e-05	0.000779	CbGpPWpGaD
Halothane—KCNMA1—Neuronal System—HRAS—skin cancer	6.64e-05	0.000779	CbGpPWpGaD
Halothane—GABRG2—Neuronal System—BRAF—skin cancer	6.62e-05	0.000776	CbGpPWpGaD
Halothane—GNG2—Neuronal System—HRAS—skin cancer	6.6e-05	0.000774	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—TERT—skin cancer	6.52e-05	0.000765	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	6.49e-05	0.000761	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—PTGER4—skin cancer	6.47e-05	0.000759	CbGpPWpGaD
Halothane—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	6.39e-05	0.00075	CbGpPWpGaD
Halothane—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	6.31e-05	0.000741	CbGpPWpGaD
Halothane—GABRQ—Transmission across Chemical Synapses—HRAS—skin cancer	6.26e-05	0.000735	CbGpPWpGaD
Halothane—ATP5D—Metabolism—ERCC2—skin cancer	6.16e-05	0.000723	CbGpPWpGaD
Halothane—ND1—Metabolism—ERCC2—skin cancer	6.16e-05	0.000723	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—KRAS—skin cancer	6.1e-05	0.000716	CbGpPWpGaD
Halothane—RHO—Disease—PTGS2—skin cancer	5.96e-05	0.000699	CbGpPWpGaD
Halothane—GABRA1—Neuronal System—BRAF—skin cancer	5.78e-05	0.000679	CbGpPWpGaD
Halothane—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	5.78e-05	0.000678	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—FOXO4—skin cancer	5.71e-05	0.00067	CbGpPWpGaD
Halothane—ALB—Vitamin B12 Metabolism—IL6—skin cancer	5.67e-05	0.000666	CbGpPWpGaD
Halothane—KCNMA1—Hemostasis—NRAS—skin cancer	5.64e-05	0.000661	CbGpPWpGaD
Halothane—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	5.61e-05	0.000658	CbGpPWpGaD
Halothane—GNG2—Hemostasis—NRAS—skin cancer	5.6e-05	0.000657	CbGpPWpGaD
Halothane—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	5.51e-05	0.000646	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—NRAS—skin cancer	5.5e-05	0.000645	CbGpPWpGaD
Halothane—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	5.41e-05	0.000635	CbGpPWpGaD
Halothane—GRIN2A—Neuronal System—HRAS—skin cancer	5.38e-05	0.000632	CbGpPWpGaD
Halothane—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	5.38e-05	0.000631	CbGpPWpGaD
Halothane—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	5.28e-05	0.00062	CbGpPWpGaD
Halothane—GABRB3—BDNF signaling pathway—HRAS—skin cancer	5.26e-05	0.000617	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—PLIN2—skin cancer	5.2e-05	0.00061	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—HRAS—skin cancer	5.19e-05	0.000608	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—BRAF—skin cancer	5.17e-05	0.000606	CbGpPWpGaD
Halothane—GABRG3—Transmission across Chemical Synapses—HRAS—skin cancer	5.16e-05	0.000605	CbGpPWpGaD
Halothane—GABRB1—Transmission across Chemical Synapses—HRAS—skin cancer	5.08e-05	0.000596	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—TP53—skin cancer	5.04e-05	0.000592	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—IL6—skin cancer	4.96e-05	0.000582	CbGpPWpGaD
Halothane—GNG2—Metabolism—ERCC2—skin cancer	4.87e-05	0.000571	CbGpPWpGaD
Halothane—KCNMA1—Hemostasis—KRAS—skin cancer	4.85e-05	0.000569	CbGpPWpGaD
Halothane—GNG2—Hemostasis—KRAS—skin cancer	4.82e-05	0.000566	CbGpPWpGaD
Halothane—GABRA6—Transmission across Chemical Synapses—HRAS—skin cancer	4.81e-05	0.000564	CbGpPWpGaD
Halothane—GABRQ—Neuronal System—HRAS—skin cancer	4.8e-05	0.000563	CbGpPWpGaD
Halothane—GABRA4—Transmission across Chemical Synapses—HRAS—skin cancer	4.75e-05	0.000557	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—KRAS—skin cancer	4.73e-05	0.000555	CbGpPWpGaD
Halothane—RHO—Disease—NRAS—skin cancer	4.64e-05	0.000544	CbGpPWpGaD
Halothane—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	4.62e-05	0.000542	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—IL6—skin cancer	4.62e-05	0.000542	CbGpPWpGaD
Halothane—GABRB2—Transmission across Chemical Synapses—HRAS—skin cancer	4.34e-05	0.000509	CbGpPWpGaD
Halothane—KCNMA1—Hemostasis—TP53—skin cancer	4.31e-05	0.000506	CbGpPWpGaD
Halothane—GNG2—Hemostasis—TP53—skin cancer	4.28e-05	0.000503	CbGpPWpGaD
Halothane—GABRA5—Transmission across Chemical Synapses—HRAS—skin cancer	4.22e-05	0.000495	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—PLIN2—skin cancer	4.19e-05	0.000492	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—CSPG4—skin cancer	4.19e-05	0.000491	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—NRAS—skin cancer	4.19e-05	0.000491	CbGpPWpGaD
Halothane—GABRA3—Transmission across Chemical Synapses—HRAS—skin cancer	4.14e-05	0.000486	CbGpPWpGaD
Halothane—KCNMA1—Hemostasis—HRAS—skin cancer	4.12e-05	0.000484	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—PLIN2—skin cancer	4.11e-05	0.000482	CbGpPWpGaD
Halothane—GNG2—Hemostasis—HRAS—skin cancer	4.1e-05	0.000481	CbGpPWpGaD
Halothane—GABRA2—Transmission across Chemical Synapses—HRAS—skin cancer	4.07e-05	0.000478	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—IL6—skin cancer	4.05e-05	0.000475	CbGpPWpGaD
Halothane—GABRB3—Transmission across Chemical Synapses—HRAS—skin cancer	4.04e-05	0.000474	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—HRAS—skin cancer	4.02e-05	0.000472	CbGpPWpGaD
Halothane—RHO—Disease—KRAS—skin cancer	3.99e-05	0.000468	CbGpPWpGaD
Halothane—GABRG2—Transmission across Chemical Synapses—HRAS—skin cancer	3.97e-05	0.000466	CbGpPWpGaD
Halothane—GABRG3—Neuronal System—HRAS—skin cancer	3.95e-05	0.000464	CbGpPWpGaD
Halothane—GABRB1—Neuronal System—HRAS—skin cancer	3.89e-05	0.000457	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—IL6—skin cancer	3.85e-05	0.000452	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—TERT—skin cancer	3.81e-05	0.000448	CbGpPWpGaD
Halothane—ATP5D—Metabolism—PTGS2—skin cancer	3.7e-05	0.000434	CbGpPWpGaD
Halothane—ND1—Metabolism—PTGS2—skin cancer	3.7e-05	0.000434	CbGpPWpGaD
Halothane—GABRA6—Neuronal System—HRAS—skin cancer	3.68e-05	0.000432	CbGpPWpGaD
Halothane—ALB—Selenium Micronutrient Network—IL6—skin cancer	3.67e-05	0.00043	CbGpPWpGaD
Halothane—GABRA4—Neuronal System—HRAS—skin cancer	3.64e-05	0.000427	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—KRAS—skin cancer	3.6e-05	0.000423	CbGpPWpGaD
Halothane—ALB—Metabolism—PLIN2—skin cancer	3.53e-05	0.000414	CbGpPWpGaD
Halothane—GABRA1—Transmission across Chemical Synapses—HRAS—skin cancer	3.47e-05	0.000407	CbGpPWpGaD
Halothane—RHO—Disease—HRAS—skin cancer	3.39e-05	0.000398	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—CSPG4—skin cancer	3.38e-05	0.000396	CbGpPWpGaD
Halothane—GABRB2—Neuronal System—HRAS—skin cancer	3.33e-05	0.00039	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—CSPG4—skin cancer	3.31e-05	0.000388	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—NRAS—skin cancer	3.25e-05	0.000381	CbGpPWpGaD
Halothane—RHO—Disease—IL6—skin cancer	3.25e-05	0.000381	CbGpPWpGaD
Halothane—GABRA5—Neuronal System—HRAS—skin cancer	3.23e-05	0.000379	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—NRAS—skin cancer	3.21e-05	0.000377	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—TP53—skin cancer	3.2e-05	0.000376	CbGpPWpGaD
Halothane—GABRA3—Neuronal System—HRAS—skin cancer	3.17e-05	0.000372	CbGpPWpGaD
Halothane—GABRA2—Neuronal System—HRAS—skin cancer	3.12e-05	0.000366	CbGpPWpGaD
Halothane—GABRB3—Neuronal System—HRAS—skin cancer	3.1e-05	0.000364	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—HRAS—skin cancer	3.06e-05	0.000359	CbGpPWpGaD
Halothane—GABRG2—Neuronal System—HRAS—skin cancer	3.04e-05	0.000357	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—BRAF—skin cancer	3.02e-05	0.000354	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—IL6—skin cancer	2.93e-05	0.000344	CbGpPWpGaD
Halothane—GNG2—Metabolism—PTGS2—skin cancer	2.92e-05	0.000342	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—PLIN2—skin cancer	2.91e-05	0.000342	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—PLIN2—skin cancer	2.89e-05	0.000339	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—ENO2—skin cancer	2.85e-05	0.000334	CbGpPWpGaD
Halothane—ALB—Metabolism—CSPG4—skin cancer	2.84e-05	0.000334	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—KRAS—skin cancer	2.79e-05	0.000328	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—KRAS—skin cancer	2.77e-05	0.000325	CbGpPWpGaD
Halothane—GABRA1—Neuronal System—HRAS—skin cancer	2.66e-05	0.000312	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—TP53—skin cancer	2.48e-05	0.000291	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—HRAS—skin cancer	2.38e-05	0.000279	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—HRAS—skin cancer	2.35e-05	0.000276	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—CSPG4—skin cancer	2.35e-05	0.000276	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—CSPG4—skin cancer	2.33e-05	0.000273	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—ENO2—skin cancer	2.3e-05	0.00027	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—IL6—skin cancer	2.27e-05	0.000267	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—IL6—skin cancer	2.25e-05	0.000264	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—ENO2—skin cancer	2.25e-05	0.000264	CbGpPWpGaD
Halothane—ALB—Metabolism—ENO2—skin cancer	1.93e-05	0.000227	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—PLIN2—skin cancer	1.91e-05	0.000224	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—NRAS—skin cancer	1.9e-05	0.000223	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—ERCC2—skin cancer	1.65e-05	0.000194	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—KRAS—skin cancer	1.63e-05	0.000192	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—ENO2—skin cancer	1.6e-05	0.000187	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—ENO2—skin cancer	1.58e-05	0.000186	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—CSPG4—skin cancer	1.54e-05	0.00018	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.51e-05	0.000177	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—TP53—skin cancer	1.45e-05	0.00017	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—HRAS—skin cancer	1.39e-05	0.000163	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—ERCC2—skin cancer	1.33e-05	0.000157	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—IL6—skin cancer	1.33e-05	0.000156	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—ERCC2—skin cancer	1.31e-05	0.000153	CbGpPWpGaD
Halothane—ALB—Hemostasis—NRAS—skin cancer	1.29e-05	0.000152	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.24e-05	0.000145	CbGpPWpGaD
Halothane—ALB—Metabolism—ERCC2—skin cancer	1.12e-05	0.000132	CbGpPWpGaD
Halothane—ALB—Hemostasis—KRAS—skin cancer	1.11e-05	0.000131	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—ENO2—skin cancer	1.04e-05	0.000122	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—PTGS2—skin cancer	9.92e-06	0.000116	CbGpPWpGaD
Halothane—ALB—Hemostasis—TP53—skin cancer	9.89e-06	0.000116	CbGpPWpGaD
Halothane—ALB—Hemostasis—HRAS—skin cancer	9.46e-06	0.000111	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—ERCC2—skin cancer	9.27e-06	0.000109	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—ERCC2—skin cancer	9.19e-06	0.000108	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—PTGS2—skin cancer	8e-06	9.39e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—PTGS2—skin cancer	7.84e-06	9.19e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—PTGS2—skin cancer	6.73e-06	7.9e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—ERCC2—skin cancer	6.06e-06	7.11e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—PTGS2—skin cancer	5.56e-06	6.52e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—PTGS2—skin cancer	5.51e-06	6.47e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—PTGS2—skin cancer	3.64e-06	4.27e-05	CbGpPWpGaD
